Mutual Fund Ownership
Ownership as on: Thu, 18 Apr, 2024

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)27.84
% of AUM2.94%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)19.59
% of AUM2.45%

Bank of India Small Cap Fund Regular Growth

4/5
Equity
Amount Invested (Cr.)18.64
% of AUM1.98%

Quantum Small Cap Fund Regular Growth

NA
Equity
Amount Invested (Cr.)0.78
% of AUM1.85%

HDFC Small Cap Fund Growth

3/5
Equity
Amount Invested (Cr.)465.65
% of AUM1.69%

FAQs about Eris Lifesciences share price

Eris Lifesciences is trading at 866.25 as on Thu Apr 18 2024 09:59:30. This is -0.16% lower as compared to its previous closing price of 867.60.

The market capitalization of Eris Lifesciences is 11785.11 Cr as on Thu Apr 18 2024 09:59:30.

The average broker rating on Eris Lifesciences is Strong Buy. The breakup of analyst rating is given below -

  • 5 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Eris Lifesciences is 971.00 whereas the 52 wk low is 596.15

Eris Lifesciences can be analyzed on the following key metrics -

  • TTM P/E: 32.03
  • Sector P/E: 30.14
  • Dividend Yield: 0.00%
  • D/E ratio: -

Eris Lifesciences reported a net profit of 382.16 Cr in 2023.

Recommended For You
Trending Stocks
1,267.20+50.50(4.15%)
1,420.55+5.80(0.41%)
3,526.40-120.65 (-3.31%)
2,462.75-84.40 (-3.31%)
HomeMarketsPremiumFor youGet App